STESTERIS plc

NYSE steris.com


$ 231.22 $ 5.34 (2.36 %)    

Friday, 10-May-2024 15:59:58 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 231.33
$ 224.74
$ 0.00 x 0
$ 0.00 x 0
$ 224.46 - $ 231.68
$ 194.49 - $ 252.21
867,834
na
22.86B
$ 0.95
$ 40.33
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-08-2024 12-31-2023 10-Q
2 11-07-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-26-2023 03-31-2023 10-K
5 02-08-2023 12-31-2022 10-Q
6 11-09-2022 09-30-2022 10-Q
7 08-08-2022 06-30-2022 10-Q
8 05-31-2022 03-31-2022 10-K
9 02-09-2022 12-31-2021 10-Q
10 11-08-2021 09-30-2021 10-Q
11 08-09-2021 06-30-2021 10-Q
12 05-28-2021 03-31-2021 10-K
13 02-09-2021 12-31-2020 10-Q
14 11-06-2020 09-30-2020 10-Q
15 08-07-2020 06-30-2020 10-Q
16 05-29-2020 03-31-2020 10-K
17 02-10-2020 12-31-2019 10-Q
18 11-07-2019 09-30-2019 10-Q
19 08-07-2019 06-30-2019 10-Q
20 05-30-2019 03-31-2019 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 piper-sandler-reiterates-neutral-on-steris-raises-price-target-to-225

Piper Sandler analyst Jason Bednar reiterates Steris (NYSE:STE) with a Neutral and raises the price target from $220 to $225.

 needham-reiterates-hold-on-steris
Needham Reiterates Hold on Steris
05/10/2024 10:06:12

Needham analyst Mike Matson reiterates Steris (NYSE:STE) with a Hold.

 jmp-securities-reiterates-market-outperform-on-steris-maintains-265-price-target

JMP Securities analyst David Turkaly reiterates Steris (NYSE:STE) with a Market Outperform and maintains $265 price target.

 steris-expects-fy25-as-reported-revenue-from-continuing-operations-to-increase-65-75-adjusted-eps-from-continuing-operations-of-905---925-est-933

Capital expenditures are anticipated to be approximately $360 million and free cash flow is expected to be approximately $700 m...

 steris-plans-restructuring-of-healthcare-surgical-business-in-europe-other-actions

STERIS today is also announcing a targeted restructuring plan, which includes restructuring of the Healthcare surgical business...

 steris-q4-2024-adj-eps-258-beats-235-estimate-sales-1419b-beat-1411b-estimate

Steris (NYSE:STE) reported quarterly earnings of $2.58 per share which beat the analyst consensus estimate of $2.35 by 9.79 per...

 needham-reiterates-hold-on-steris
Needham Reiterates Hold on Steris
04/12/2024 08:39:39

Needham analyst Mike Matson reiterates Steris (NYSE:STE) with a Hold.

 steris-enters-definitive-deal-to-divest-its-dental-segment-to-peak-rock-capital-for-7875m

The Transaction is structured as an equity sale. The Transaction terms also include the opportunity for STERIS to receive an ad...

 stephens--co-reiterates-overweight-on-steris-maintains-250-price-target

Stephens & Co. analyst Jacob Johnson reiterates Steris (NYSE:STE) with a Overweight and maintains $250 price target.

 jmp-securities-reiterates-market-outperform-on-steris-maintains-265-price-target

JMP Securities analyst David Turkaly reiterates Steris (NYSE:STE) with a Market Outperform and maintains $265 price target.

 recap-steris-q3-earnings
Recap: Steris Q3 Earnings
02/07/2024 21:40:23

 steris-now-expects-fy24-as-reported-revenue-to-increase-10-11-up-from-previous-expectations-of-9-10-revises-adjusted-eps-outlook-from-860-880-to-860-870-est-867

Adjusted earnings per diluted share revised due primarily to a shift in operating income mix from AST to Healthcare.  

 steris-q3-adj-eps-222-beats-217-estimate

Steris (NYSE:STE) reported quarterly Adj earnings of $2.22 per share which beat the analyst consensus estimate of $2.17 by 2.3 ...

 earnings-scheduled-for-february-7-2024

Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per shar...

 earnings-outlook-for-steris
Earnings Outlook For Steris
02/06/2024 18:02:08

 keybanc-initiates-coverage-on-steris-with-overweight-rating-announces-price-target-of-253

Keybanc analyst Brett Fishbin initiates coverage on Steris (NYSE:STE) with a Overweight rating and announces Price Target of...

Core News & Articles

At the end of today, December 21, 2023, Steris (NYSE:STE) will distribute a dividend payout of $0.52 per share, translating to ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION